Amicus Therapeutics
FOLD
#3300
Rank
โ‚น435.41 B
Marketcap
โ‚น1,387
Share price
0.00%
Change (1 day)
168.07%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2025 (TTM): โ‚น0.14 Billion

According to Amicus Therapeutics 's latest financial reports the company's current earnings are โ‚น0.63 Billion. , an increase over its 2024 earnings that were of -โ‚น2.76 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น18.27 M-100.66%
2024 -โ‚น2.76 Billion-80.84%
2023 -โ‚น14.37 Billion-37.98%
2022 -โ‚น23.17 Billion0.2%
2021 -โ‚น23.12 Billion-11.92%
2020 -โ‚น26.25 Billion-22.94%
2019 -โ‚น34.06 Billion1.95%
2018 -โ‚น33.41 Billion-22.27%
2017 -โ‚น42.98 Billion120.39%
2016 -โ‚น19.51 Billion54.24%
2015 -โ‚น12.65 Billion88.63%
2014 -โ‚น6.71 Billion10.92%
2013 -โ‚น6.05 Billion21.36%
2012 -โ‚น4.98 Billion8.3%
2011 -โ‚น4.6 Billion-14.33%
2010 -โ‚น5.37 Billion753.76%
2009 -โ‚น0.63 Billion-83.31%
2008 -โ‚น3.77 Billion-4.4%
2007 -โ‚น3.94 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚น2.393 T 13,095,135.60%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
โ‚น155.31 B 849,638.22%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น958.07 B 5,241,470.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-โ‚น6.57 Billion-36,004.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.63 Billion-14,467.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.90 B 201,781.68%๐Ÿ‡บ๐Ÿ‡ธ USA